Patents by Inventor Daishui SU

Daishui SU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250213679
    Abstract: Disclosed herein are polynucleotides comprising a first nucleic acid encoding a first pathogen antigen and, optionally, a second nucleic acid encoding a second pathogen antigen, and, optionally, a nucleic acid encoding an immune modifier. In some aspects, the first pathogen antigen is a SARS-CoV-2 spike protein or antigenic fragment thereof. In some aspects, the second pathogen antigen is a SARS-CoV-2 protein or an antigenic fragment thereof. In some aspects, polynucletide includes two or more different immune modifiers. Also disclosed herein are vectors, compositions, pharmaceutical compositions, vaccines, lyophilized compositions, and cells comprising such polynucleotides. Methods of production and therapeutic use are also disclosed herein.
    Type: Application
    Filed: October 2, 2021
    Publication date: July 3, 2025
    Inventors: Khursheed ANWER, Jason Glenn FEWELL, Majed Mohd MATAR, Anthony Joseph RECUPERO, Brian Jeffrey SPARKS, Daishui SU, Michael Henry TARDUGNO, Carlo IAVARONE, Subeena SOOD, John HENDERSON, Jessica KIM
  • Patent number: 10251901
    Abstract: The present invention relates to a formulation of thermosensitive liposomes, and more specifically to a formulation of liposomes comprising phospholipids and a surface active agent, wherein the liposomes support long term storage at temperatures less than or equal to about 8° C., control degradate formation to maximize product potency and release their contents at mild hyperthermic temperatures. Methods of making formulations are also described.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: April 9, 2019
    Assignee: Celsion Corporation
    Inventors: Robert A. Reed, Daishui Su
  • Publication number: 20170080003
    Abstract: The present invention relates to a formulation of thermosensitive liposomes, and more specifically to a formulation of liposomes comprising phospholipids and a surface active agent, wherein the liposomes support long term storage at temperatures less than or equal to about 8° C., control degradate formation to maximize product potency and release their contents at mild hyperthermic temperatures. Methods of making formulations are also described.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 23, 2017
    Inventors: Robert A. Reed, Daishui SU
  • Publication number: 20130230457
    Abstract: The present invention relates to a formulation of thermosensitive liposomes, and more specifically to a formulation of liposomes comprising phospholipids and a surface active agent, wherein the liposomes support long term storage at temperatures less than or equal to about 8° C., control degradate formation to maximize product potency and release their contents at mild hyperthermic temperatures. Methods of making formulations are also described.
    Type: Application
    Filed: February 15, 2013
    Publication date: September 5, 2013
    Applicant: CELSION CORPORATION
    Inventors: Robert A. REED, Daishui SU